Partial
“Dr. Berg TUDCA supports liver, bile flow and gallbladder health.”
TUDCA has a sound bile-flow mechanism (PMID 16741551), but there is no OTC human outcome trial validating these endpoints for this product, and it's a standard 250mg dose.
Reviewed
Verified by SAC team
+20
XP on completion
Practitioner-Brand Premium
Dr. Berg
Dr. Berg TUDCA Supplement, 30 Capsules Review
6.1/10SAC Product Score™
Dr. Berg's TUDCA is a competent single-ingredient 250mg vegetable capsule marketed for liver, bile flow and gallbladder support. The problem is the math: at roughly $1.17 per capsule it's the most expensive per dose in this entire roundup, and the small 30-count bottle means you're refilling monthly. It doesn't add a milk-thistle or NAC stack, doesn't publish deeper testing than mainstream rivals, and doesn't offer a higher dose. What you're buying is the practitioner brand and its audience trust — a real thing for some buyers, but not one that shows up in the capsule.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete TUDCA guide →How we built the SAC Product Score™ — 6.1/10
Form, Bioavailability & Purity25%6.5/10
Standard 250mg TUDCA in a vegetable capsule (a plus for vegetarians). Purity is fine but no different in kind from cheaper mainstream options.
Third-Party Testing30%6/10
Non-GMO, gluten-free, GMP — baseline quality assurance, but no published HPLC-vs-USP or dual-lab program to justify the premium over better-tested rivals.
Dose vs Clinical Range20%6.5/10
250mg/cap at the low end of the range; the 30-count bottle makes a sustained 500mg/day habit both expensive and inconvenient to maintain.
Tolerability & Safety10%7/10
Well tolerated single-ingredient 250mg with the usual mild bile effects. Veg-cap shell suits vegetarians. No specific concerns.
Value15%4.5/10
~$1.17/cap is the highest per-dose price here, in a small 30-count bottle. The premium buys brand, not extra testing, dose, or a stack — the weakest value in the roundup.
The product at a glance
- Form
- Vegetable capsule (single-ingredient)
- Dose
- 250mg per capsule
- Count
- 30 capsules
- Standardization
- Single-ingredient, non-GMO, gluten-free
- Testing
- GMP facility; standard quality assurance
- Cost per dose
- ~$1.17/cap · ~$2.34 per 500mg/day
Marketing claims vs. reality
Not verified
“The premium price reflects higher product quality.”
No published testing, dose, or formulation advantage over cheaper rivals justifies the ~$1.17/cap price; the premium appears to reflect brand rather than verifiable quality.
What our test actually found
01The price doesn't buy anything extra
At more than double Nutricost's per-cap cost, Dr. Berg offers the same 250mg dose, no stack, and no deeper published testing. The premium is brand equity — legitimate to value, but it isn't verification you can point to on a COA.
02Small bottle compounds the cost
A 30-count bottle at 250mg means one month at best, and running 500mg/day burns it in 15 days at ~$2.34 daily. For an ongoing regimen the economics are the worst here.
Pros & cons, no sugar-coating
Pros
- Vegetarian-friendly veg-cap shell
- Clean single-ingredient 250mg formulation
- Reputable practitioner brand with strong audience trust
Cons
- Most expensive per dose in the roundup (~$1.17/cap)
- Small 30-count bottle, frequent reorders
- No published testing, dose, or stack advantage to justify the premium
Pay for the brand, not the bottle
Dr. Berg's TUDCA is a fine 250mg capsule wrapped in a premium the product doesn't earn — no deeper testing, no bigger dose, no stack, and the smallest, priciest bottle here. If brand trust genuinely drives your decision, it's competent. On a clear-eyed value-and-verification basis, Nutricost and Double Wood beat it decisively. Skip unless loyalty is the point.
Check Dr. Berg on AmazonIf this doesn’t fit — try these
Sources & further reading
- Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(6):318-328.Beuers U · 2006 · Nature Clinical Practice Gastroenterology & Hepatology · PMID 16741551
Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
Establishes the bile-flow and cytoprotective mechanisms behind liver/gallbladder support claims for TUDCA.
- Rudic JS, et al. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev. 2012;12:CD000551.Rudic JS, Poropat G, Krstic MN, et al. · 2012 · Cochrane Database of Systematic Reviews · PMID 23235576
Ursodeoxycholic acid for primary biliary cirrhosis
Cochrane review showing biochemical improvement without proven mortality benefit — a reminder that brand marketing outruns the outcome evidence.